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OBJECTIVE — Bariatric surgery is gaining acceptance as an efﬁcient treatment modality for
obese patients. Mechanistic explanations regarding the effects of bariatric surgery on body
composition and fat distribution are still limited.
RESEARCH DESIGN AND METHODS — Intra-abdominal and subcutaneous fat de-
pots were evaluated using computed tomography in 27 obese patients prior to and 6 months
following bariatric surgery. Associations with anthropometric and clinical changes were
evaluated.
RESULTS — Excess weight loss 6 months following surgery was 47% in male and 42.6% in
female subjects. Visceral fat and subcutaneous fat were reduced by 35% and 32%, respectively,
in both sexes, thus the visceral-to-subcutaneous fat ratio remained stable. The strongest relation
betweenabsoluteandrelativechangesinvisceralandsubcutaneousfatwasdemonstratedforthe
excessweightlossfollowingtheoperations(r0.6–0.7),andtheserelationswerestrengthened
further following adjustments for sex, baseline BMI, and fat mass. Changes in waist circumfer-
ence and fat mass had no relation to changes in abdominal fat depots. All participants met the
criteria of the metabolic syndrome at baseline, and 18 lost the diagnosis on follow-up. A lower
baseline visceral-to-subcutaneous fat ratio (0.43  0.15 vs. 0.61  0.21, P  0.02) was asso-
ciated with clinical resolution of metabolic syndrome parameters.
CONCLUSIONS — The ratio between visceral and subcutaneous abdominal fat remains
fairly constant 6 months following bariatric procedures regardless of sex, procedure performed,
or presence of metabolic complications. A lower baseline visceral-to-abdominal fat ratio is
associated with improvement in metabolic parameters.
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B
ariatric surgery is gaining accep-
tance as an efﬁcient treatment mo-
dality for patients with class 2 and
class 3 obesity. Various bariatric proce-
dures have been reported to lead not only
to signiﬁcant weight reduction but also to
improvement or disappearance of the
typicalcomorbiditiesofobeseindividuals
(altered glucose metabolism, hyperten-
sion,anddyslipidemia)(1).Theseresults,
especially for long-term follow-up (2),
seem very promising in comparison with
lifestyle modiﬁcations and pharmacolog-
ical interventions, which have limited
long-term success against obesity (3,4).
Despite these observations, mechanistic
explanations regarding the effects of such
procedures on body composition, fat dis-
tribution, and hormonal alterations are
still limited.
Abdominal fat is composed of subcu-
taneous fat and intra-abdominal fat (5).
These two depots have a major inﬂuence
on the metabolic phenotype of obese in-
dividualsanddifferintheirhormonaland
cytokine secretion proﬁle as well in their
anatomical vascular drainage (6). In-
creased intra-abdominal fat is associated
withanadversemetabolicproﬁleandpre-
dicts the development of type 2 diabetes
(7)andcardiovasculardisease(8).Theef-
fects of weight loss induced by lifestyle
modiﬁcations (9) and pharmacotherapy
(10) on abdominal fat depots have been
described, yet the short-term impact of
bariatric procedures on these depots is
unknown. Because bariatric procedures
are characterized by a signiﬁcant rapid
weight loss that includes a substantial
amountoffatduringtheﬁrstmonthsafter
surgery, our aim was to test the impact of
such surgery on abdominal fat depots 6
months after surgery. We further tested
the relation of changes in the content of
fat in the abdominal depots and improve-
ment of the metabolic phenotype.
RESEARCH DESIGN AND
METHODS— Twenty-seven morbidly
obese adults undergoing bariatric surgery
at the Hadassah Medical Center were re-
cruited for this study. Procedures in-
cluded laparoscopic gastric banding,
sleeve gastrectomy, laparoscopic Roux en
Y gastric bypass, and duodenal switch
procedures. All patients met the criteria
for bariatric operations as recommended
by the National Institutes of Health Con-
sensus Conference (11). Pre- and postop-
erative anthropometric measures included
heighttothe nearestcentimeter,weightto
thenearest0.1kg,andwaist(measuredat
the midpoint between the costal margin
andtheiliaccrest)andhipcircumference.
Patientswereseenattheobesityclinicbe-
fore surgery and then monthly after sur-
gery in the ﬁrst month. Blood tests
performed before and after surgery at 6
months included a blood count, general
chemistry analysis, liver and kidney func-
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fat depots were evaluated using com-
puted tomography scans before and at 6
months after surgery. Visceral and subcu-
taneous adipose tissue cross-section areas
were calculated using computer software
speciﬁcally designed for area measure-
ment (12). Body composition was as-
sessed using bioelectrical impedance
analysis (Tanita 305 body fat analyzer;
Tanita, Tokyo, Japan). Clinical parame-
ters related to the metabolic syndrome
wereevaluatedusingtheAdultTreatment
Panel III criteria (13). Resolution of these
parameters was considered as drug dis-
continuation with normal measurements
of fasting glucose, systolic and diastolic
blood pressure, and normalization of tri-
glyceride or HDL cholesterol levels. The
study was approved by the institutional
review board at the Hadassah Hebrew
University Medical Center and registered
in the National Institutes of Health Proto-
col Registration System.
Statistical analysis
DataarepresentedasmeansSD.Group
comparisons between men/women and
between those who lost the diagnosis of
metabolic syndrome were performed us-
ing Wilcoxon’s rank-sum test. P  0.05
was considered signiﬁcant. All analyses
were performed using SPSS 15.0 for
Windows.
RESULTS— Twenty-seven subjects
underwent laparoscopic bariatric surgery
that included Roux en Y gastric bypass
(n  14), sleeve gastrectomy (n  7),
laparoscopic gastric banding (n  2), and
duodenal switch (n  4). Baseline and
follow-up anthropometric characteristics
of the groups according to sex are shown
in Table 1. Participants had an excess
body weight of 52.2  15.1 kg (women)
and 66.0  10.5 kg (men) at baseline.
Absoluteweightlossandanexcessweight
loss at 6 months were 31.3  9.6 kg and
47  12% in men and 22.0  8.7 kg and
42  13% in women. In women, fat mass
represented 55% of total weight loss,
whereas in men it represented 70% of the
total weight loss. Visceral fat was 35%
lower on follow-up compared with base-
line in both sexes, whereas subcutaneous
fat was 32% lower on follow-up com-
pared with baseline in both sexes. Thus,
the visceral-to-subcutaneous fat ratio re-
mained stable after surgically induced
weight loss despite the signiﬁcant weight
loss observed.
Clinical characteristics of study par-
ticipants associated with the metabolic
syndrome before and 6 months after sur-
geryareshowninTable2.Allparticipants
met the waist circumference threshold
before surgery, and all men kept it on fol-
low-up, whereas two women reduced
their waist circumference below the
threshold of 88 cm. Diabetes was present
in 10 of 13 men and in 11 of 14 women
before surgery and only 2 men and 4
womencontinuedtotakeantihyperglyce-
mic medications on follow-up. Similarly,
signiﬁcant improvements were observed
in triglyceride levels and in the presence
of hypertension. The prevalence of a low
HDLcholesterolleveldidnotchangeafter
surgery.
Relations of anthropometric changes
and fat depots changes in study
participants
The strongest relation between absolute
and relative changes in visceral and sub-
cutaneous fat was demonstrated for the
excess weight loss after the operations
(r  0.6–0.7), and this relation was
strengthened further for subcutaneous fat
after adjustment for sex, baseline BMI,
and fat mass (Table 3). Changes in weight
andBMIcorrelatedwithabsolutechanges
in abdominal fat depots, and the relation
with changes in subcutaneous fat were
signiﬁcantly strengthened after adjust-
ment for sex, baseline BMI, and fat mass.
Changesinwaistcircumferenceandinfat
Table 1—Anthropometric parameters and abdominal fat depots before and after surgery
Men (n  13) Women (n  14)
Before After P Before After P
n 13 14
Age (years) 49  10 49  11 0.96
Weight (kg) 134  13 103  11 0.001 104  18 82  14 0.001
Height (cm) 175  9 157  7
BMI (kg/m
2) 43.7  4.6 33.5  3.2 0.001 41.9  5.4 33.1  4.6 0.001
Excess weight (kg) 66.0  10.5 34.7  8.8 0.001 52.2  15.1 30.2  12.1 0.001
Excess weight loss (%) 47  13 42  13 0.36
Fat mass (kg) 48.9  6.1 31.6  5.8 0.001 51.2  11.7 35.7  9.5 0.001
Fat mass lost (kg) 17.3 15.5 0.43
Waist circumference (cm) 135  7 115  12 0.001 123  13 104  11 0.001
Visceral fat (cm) 163  40 102  30 0.001 126  36 81  21 0.001
Subcutaneous fat (cm) 309  52 206  51 0.001 306  79 218  85 0.001
Visceral-to-subcutaneous ratio 0.54  0.15 0.50  0.12 0.37 0.44  0.21 0.44  0.27 0.99
Data are means SD.
Table 2—Presence of metabolic syndrome criteria before and after surgery
Before surgery After surgery
Men Women P Men Women P
Hypertension 13/0 11/3 0.12 4/9 5/9 0.55
Diabetes 10/3 11/3 0.63 2/11 4/10 0.36
High triglyceride 11/2 10/4 0.36 2/11 3/11 0.53
Low HDL cholesterol 9/4 9/5 0.55 10/3 9/5 0.38
High waist circumference 13/13 14/14 1.0 13/13 12/2 0.25
Data are n.
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dominal fat depots.
Relation of changes in abdominal fat
depots and metabolic parameters
All study subjects met the criteria of the
metabolic syndrome before surgery, and
18 of them did not meet these criteria at
follow-up. When comparing those who
lost the diagnosis on follow-up with
those who did not (Table 4), we found
no sex or procedure differences be-
tween the groups, yet those who did not
meet the criteria of the syndrome after
surgery were signiﬁcantly younger (45 
9 vs. 57  10 years, P  0.01). The base-
line numbers of metabolic syndrome cri-
teria, BMI, fat mass, and excess weight
were comparable between the groups.
BMI,excessweightloss,andfatmassafter
the surgery were similar between the
groups. As shown in Fig. 1A, excess
weight loss on the follow-up was compa-
rable between those who met the criteria
of the metabolic syndrome on follow-up
and those who did not. The only signiﬁ-
cant baseline difference between the
groups was in the absolute amount of vis-
ceral fat (Fig. 1B), which was greater in
those who did not lose the diagnosis
(166  49 vs. 132  33 cm, P  0.04).
This difference translated to a signiﬁ-
cantly greater visceral-to-subcutaneous
fat ratio (0.61  0.21 vs. 0.43  0.15,
P  0.02) (Fig. 1D). Similarly, both
groups had similar amounts of subcuta-
neous (Fig. 1C) abdominal fat at baseline
andacomparablereductionaftersurgery.
Thus, all subjects lost a comparable sig-
niﬁcant amount of fat from both abdom-
inal fat depots yet maintained a constant
ratio between these depots.
CONCLUSIONS — This study dem-
onstrates for the ﬁrst time the early pat-
tern of change in abdominal fat depots 6
months after bariatric procedures in se-
verely obese subjects. The most consis-
tent ﬁnding is that the ratio between
visceral and subcutaneous abdominal fat
remains fairly constant regardless of sex,
procedure performed, or the presence of
metabolic complications. Excess weight
loss was associated with a reduction in fat
in both abdominal fat depots more
strongly than other anthropometric mea-
sures, whereas changes in waist circum-
ference or fat mass had no relation with
this reduction. A lower baseline visceral-
to-abdominal fat ratio was the determi-
nant of the improvement in metabolic
parameters.
Lipid partitioning of speciﬁc fat de-
pots in obese subjects is known to be as-
sociated with the overall metabolic
phenotype (14,15). Speciﬁcally, intra-
abdominal fat is associated with greater
Table 4—Anthropometric parameters before surgery and their changes in those who lost the
diagnosis of the metabolic syndrome compared with those who did not 6 months after surgery
Lost MS Remained MS P
n 18 9
Age (years) 45  95 7  10 0.01
Sex (male/female) 9/9 4/5 0.55
Procedure (RYGB/LAGB/SG/DS) 9/0/5/4 5/2/2/0 0.10
MS score before 3.9  0.2 4.4  0.2 0.11
MS score after 1.8  0.3 3.33  0.5 0.001
Weight before (kg) 120.7  19.7 115.1  25.7 0.46
Weight after (kg) 92.4  15.1 92.3  19.1 0.86
BMI before (kg/m
2) 43.5  5.3 41.2  4.4 0.27
BMI after (kg/m
2) 33.3  4.0 33.1  3.9 0.70
Excess weight (kg) 60.5  13.6 55.6  16.9 0.42
Excess weight loss (%) 46.6  14.0 41.4  10.8 0.99
Fat mass before (kg) 52.8  10.2 46.2  9.2 0.17
Fat mass after (kg) 34.9  8.4 33.7  9.3 0.71
Data are means  SD. DS, duodenal switch; LAGB, laparoscopic gastric banding; MS, metabolic syndrome;
RYGB, Roux en-Y gastric bypass; SG, sleeve gastrectomy.
Table 3—Correlations between changes in anthropometric indices and changes in abdominal fat depots
 Weight
(%)
 BMI
(5)
 Waist
circumference (cm)
 Fat
mass (kg)
 Visceral
(cm)
 Visceral
(%)
 Subcutaneous
(cm)
 Subcutaneous
(%)
Excess weight loss (%) 0.75* 0.71* 0.31 0.51† 0.62* 0.63* 0.62* 0.71*
Adjusted 0.96* 0.99* 0.46 0.71† 0.58† 0.57† 0.73† 0.80*
 weight (%) 0.91* 0.60† 0.78* 0.50† 0.43† 0.53† 0.37
Adjusted 0.97* 0.48 0.69† 0.51 0.47 0.70* 0.78*
 BMI (%) 0.65† 0.77* 0.45† 0.46† 0.51* 0.32
Adjusted 0.48 0.72† 0.55† 0.55† 0.77* 0.82*
 waist circumference
(cm) 0.38 0.03 0.03 0.39 0.11
Adjusted 0.12 0.01 0.01 0.38 0.43
 fat mass (kg) 0.18 0.07 0.05 0.13
Adjusted 0.43 0.47 0.42 0.43
 visceral (cm) 0.91* 0.59* 0.66*
Adjusted 0.88* 0.61† 0.47
 Visceral (%) 0.59* 0.64*
Adjusted 0.41 0.50
 subcutaneous (cm) 0.87*
Adjusted 0.96*
All changes are in their absolute value of change. Adjusted correlations are adjusted for sex, baseline BMI, and baseline fat mass. *P  0.001; †P  0.01.
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scribed as a culprit for accelerated athero-
genesis and altered glucose metabolism.
Standard interventions for obese individ-
uals consist of lifestyle modiﬁcations that
include dietary changes and physical ac-
tivity. Diet-induced modest weight loss
has been shown to affect visceral fat pref-
erentially, whereas with larger degrees of
weight loss the effect was shown to be
similar for both visceral and subcutane-
ous fat (16). For every 1 kg of diet-
induced weight loss, the corresponding
reduction in visceral fat expressed in ab-
solute terms is 3–4 cm
2, and a 1-cm
reduction in waist circumference corre-
spondstoa5-cm
2reductioninvisceralfat
area (17). In our subjects, mean visceral
fat area reduction was 53.1  35 cm
2 (a
reductionof34.517.1%).Meanweight
loss in 6 months was 26.4  10.2 kg (2
cm
2 or 1.32% of visceral fat/kg weight
lost), whereas mean waist circumference
reductionwas18.59.2cm(3cm
2or
1.85%ofvisceralfatpercmwaistcircum-
ference reduction). Importantly, the
strongest relation of visceral fat changes
was with the excess weight lost, whereas
changesinwaistcircumferencehadnore-
lation whatsoever with the reduction in
visceral fat or subcutaneous fat. Our sub-
jects were more severely obese and had a
greater absolute weight loss than those
described in the previous references,
which may provide some explanation for
the seemingly lower visceral fat reduction
in relation to weight loss. Whereas previ-
ous studies have shown a preferential loss
ofvisceralfatintheearlyphasesafterbari-
atric surgery (8–10 weeks) (18,19), min-
imal changes in peripheral insulin
sensitivity were observed. These results
suggest that the ratio between abdominal
andsubcutaneousfat,whichaccordingto
our data is rather stable, is one of the de-
terminants of overall insulin sensitivity
and of its clinical consequences.
Whether the absolute amount of
visceral fat has a threshold above which
metabolic derangements tend to occur
or whether the ratio of visceral-to-
subcutaneous fat is the main determinant
of such derangements (or maybe both) is
debatable. In both men and women, a
value of 100 cm
2 of visceral fat has been
shown to be associated with signiﬁcant
alterations in cardiovascular disease risk
proﬁle and a further deterioration in the
metabolic proﬁle was observed with val-
ues 130 cm
2 of visceral adipose tissue
(20).Participantsinourstudyhadgreater
visceral fat before surgery than those de-
scribed in previous studies, yet a signiﬁ-
Figure 1—Comparison of excess weight lost (A), visceral fat change (B), subcutaneous fat change (C), and the visceral-to-subcutaneous fat ratio
(D) between those who lost the diagnosis of the metabolic syndrome (No MS) and those who did not (MS). *P  0.001; **P  0.01; †P  0.03.
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2
after the bariatric procedure, correlating
well with the signiﬁcant improvement in
metabolic parameters (the mean visceral
fat area in the group who lost the diagno-
sis of metabolic syndrome was 86.6 
26.5 cm
2).
On the other hand, a ratio of visceral-
to-subcutaneous fat of 0.4 has been sug-
gested to be a threshold value that
signiﬁes metabolic risk (21). Indeed, the
patients who did not lose the diagnosis of
the metabolic syndrome had a high vis-
ceral-to-subcutaneous fat ratio to begin
with,andthisratiodidnotchangedespite
signiﬁcant weight loss. In comparison
with exercise regimens, which have been
reported to reduce the visceral-to-
subcutaneous ratio by up to 33% (22),
treatment with metformin showed no
change in the relation of abdominal fat
depots despite a signiﬁcant weight loss
(23) and thiazoladinediones reduced this
ratio by way of increasing the amount of
subcutaneous fat (24). It seems that rapid
weight loss induced by bariatric surgical
procedures, which can be considered a
periodofaverylowcaloriediet,inducesa
proportional decrease in both abdominal
fat depots, resulting in a maintained ratio
between them. Because both the absolute
amount of visceral fat and the visceral-to-
subcutaneousfatratioaredeterminantsof
the clinical metabolic characteristics of
obeseindividuals,alowerratioatbaseline
probably raises the chances of clinical im-
provement because the ratio remains
fairlyconstantduetoproportionalfatloss
from both depots. However, the “visceral
threshold”isprobablycrossedbacktothe
tolerable range (25).
This study is limited by the modest
sample size, short follow-up period, and
the variability of procedures performed,
which differ in their malabsorption com-
ponent and may thus have a different im-
pact on lipid partitioning after surgery.
Therefore,althoughwewereinterestedin
the impact of surgically induced rapid
weight loss on lipid depot distribution in
general, speciﬁc procedures at different
ages may differ in their overall impact.
The ﬁndings raise the possibility of add-
ing parameters in addition to BMI as in-
dications and predictors of the metabolic
response to bariatric procedures. Present
indications for bariatric surgery are based
(11) only on BMI and obesity-related co-
morbidity and disregard lipid partition-
ing patterns. Our ﬁndings suggest that
baseline assessment of abdominal fat de-
pots may add information regarding the
expected early clinical response, whereas
changes in waist circumference correlate
poorly with visceral fat reduction. Longer
follow-up is still needed to determine
whethertheobservedchangesremainsta-
ble over longer periods.
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